Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RAS
RAS
Immuneering takes aim at cancer’s ‘superhighway’
Pharma Voice
Mon, 09/11/23 - 06:50 pm
Immuneering
Neuroscience
cancer
oncology
RAS
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
Xconomy
Thu, 02/13/20 - 12:06 am
IPOs
RAS
cancer
Revolution Medicines